<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>大叔快评 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-01T13:38:24+08:00</updated>
  <subtitle>肿瘤学临床研究及制药企业研发评述</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020年NMPA批准新药48款</title>
    <updated>2021-01-01T11:39:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/FVEm6wBZXqDvtIuCkvdiTQ</id>
    <link href="https://mp.weixin.qq.com/s/FVEm6wBZXqDvtIuCkvdiTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥希替尼联合Navitoclax的IB期研究结果</title>
    <updated>2021-01-01T11:39:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/U4vxUo8funBuYxEhvZDewg</id>
    <link href="https://mp.weixin.qq.com/s/U4vxUo8funBuYxEhvZDewg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家卫健委:研究者发起的临床研究管理办法</title>
    <updated>2020-12-31T17:27:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/Ae-31IcmvuCVxvYHLuJlYQ</id>
    <link href="https://mp.weixin.qq.com/s/Ae-31IcmvuCVxvYHLuJlYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医学策略的几个误区</title>
    <updated>2020-12-30T20:26:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/kZyM6EkkdcGk7tCZ6s-xbQ</id>
    <link href="https://mp.weixin.qq.com/s/kZyM6EkkdcGk7tCZ6s-xbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>马军教授：淋巴瘤靶向治疗进展</title>
    <updated>2020-12-30T20:26:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/QjaR33_10OeYOT9d991SqA</id>
    <link href="https://mp.weixin.qq.com/s/QjaR33_10OeYOT9d991SqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Lancet Haematol | BV治疗儿童复发难治性HL或ALCL效果显著、且不良反应基本可控</title>
    <updated>2020-12-30T20:26:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/TWVO2rCyMVATINzMCg9hGg</id>
    <link href="https://mp.weixin.qq.com/s/TWVO2rCyMVATINzMCg9hGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判结果公布：这3种血液领域的药进啦！</title>
    <updated>2020-12-30T20:26:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/oRriZN67AcrGOvIjDJGyAw</id>
    <link href="https://mp.weixin.qq.com/s/oRriZN67AcrGOvIjDJGyAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>为何外企的PD-1谈不进医保</title>
    <updated>2020-12-28T21:55:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/s_YN2I33gVTOmfrRVHEqcQ</id>
    <link href="https://mp.weixin.qq.com/s/s_YN2I33gVTOmfrRVHEqcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年快到了，立个flag吧</title>
    <updated>2020-12-28T00:05:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/Vsu4bm9dQWpjWbwbZNxYWw</id>
    <link href="https://mp.weixin.qq.com/s/Vsu4bm9dQWpjWbwbZNxYWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>血友病A患者根据药代动力学预防治疗的临床观察结果</title>
    <updated>2020-12-24T22:09:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/cEdIr8zC98g8vvNmvz8nog</id>
    <link href="https://mp.weixin.qq.com/s/cEdIr8zC98g8vvNmvz8nog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>波齐替尼Poziotinib谋求上市和新给药剂量方案</title>
    <updated>2020-12-24T22:09:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/ZNBGnmbwkYDtwmYxSyNzFw</id>
    <link href="https://mp.weixin.qq.com/s/ZNBGnmbwkYDtwmYxSyNzFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥希替尼说明书2020年12月更新内容</title>
    <updated>2020-12-24T22:09:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/tZJcGf8gsXyzbKqI--OzJQ</id>
    <link href="https://mp.weixin.qq.com/s/tZJcGf8gsXyzbKqI--OzJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>看清“势”的底色</title>
    <updated>2020-12-22T21:37:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/5niTqMBUj_0cJba-XlDZ3g</id>
    <link href="https://mp.weixin.qq.com/s/5niTqMBUj_0cJba-XlDZ3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田中国与丁香园签订战略合作协议，共探医药数字化营销生态范式</title>
    <updated>2020-12-22T21:37:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/ooL3O3GaZg5KwniN9k-Hzg</id>
    <link href="https://mp.weixin.qq.com/s/ooL3O3GaZg5KwniN9k-Hzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>确定了，医学联络官也需备案管理</title>
    <updated>2020-12-21T16:52:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/q78HUP5M6d1bQKPX1BrkQg</id>
    <link href="https://mp.weixin.qq.com/s/q78HUP5M6d1bQKPX1BrkQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CD30学院 | 宋玉琴教授——外周T细胞淋巴瘤治疗新进展</title>
    <updated>2020-12-21T16:52:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/PW5404a6zaalzJd8SHOvEg</id>
    <link href="https://mp.weixin.qq.com/s/PW5404a6zaalzJd8SHOvEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准口服relugolix用于治疗晚期前列腺癌</title>
    <updated>2020-12-19T21:48:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/Q_mHm0m0iiqh7XYbOwx2cA</id>
    <link href="https://mp.weixin.qq.com/s/Q_mHm0m0iiqh7XYbOwx2cA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准武田ICLUSIG用于治疗CP-CML前序耐药或不耐受的成年患者</title>
    <updated>2020-12-19T21:48:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/aRxnsM8JD7JoEgwrFN7Nzw</id>
    <link href="https://mp.weixin.qq.com/s/aRxnsM8JD7JoEgwrFN7Nzw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【资讯】FDA批准Selinexor用于难治/复发性多发性骨髓瘤</title>
    <updated>2020-12-19T21:48:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/Flx-TmCjXccwr4LqW1k-DA</id>
    <link href="https://mp.weixin.qq.com/s/Flx-TmCjXccwr4LqW1k-DA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥希替尼获FDA批准用于NSCLC辅助治疗</title>
    <updated>2020-12-19T11:54:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/2M07wGQUIlLOzcrIA6uuFQ</id>
    <link href="https://mp.weixin.qq.com/s/2M07wGQUIlLOzcrIA6uuFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>